Management of erysipelas.

Authors
Citation
F. Granier, Management of erysipelas., MED MAL INF, 30, 2000, pp. 315S-330S
Citations number
74
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
MEDECINE ET MALADIES INFECTIEUSES
ISSN journal
0399077X → ACNP
Volume
30
Year of publication
2000
Supplement
4
Pages
315S - 330S
Database
ISI
SICI code
0399-077X(200011)30:<315S:MOE>2.0.ZU;2-R
Abstract
The objective of this literature review was to evaluate the therapeutic man agement of erysipelas. We selected 74 publications, some of written a long time ago, and thus open to criticism regarding their methodology However; n o recent or better study was available on the subject. Penicillin G remains the therapeutic reference. The use of macrolides and stretogramins is an a lternative after the exclusion of severe forms of erysipelas. The preventiv e treatment of thrombosis by heparin must be discussed taking into account risk factors. More studies are necessary to suggest a coprescription cortic oid/NSAIDs and antibiotherapy. The best antibiotic prophylaxis after the in itial treatment is a benzathine-penicillin injection every 15 days. (C) 200 0 Editions scientifiques et medicales Elsevier SAS.